NeuroSwift® Pro: Advanced Eye Tracking for Precise Vestibular and Neurological Diagnosis

Neurobit Technologies Co., Ltd.

Taipei, Taiwan

Neurobit Technologies was founded in Taipei, Taiwan. The company is structured into five main teams: Management, Sales, Manufacturing, Research Development, and Quality Control. Neurobit Technologies core expertise includes high-interference-resistant eye-tracking technology, capable of outputting pupil center and gaze position with angular correction. The company also excels in report algorithm technology with self-calibration capabilities, ensuring data stability, as well as AIVertigo, a technology that aids in evaluating brain disorders. Neurobit's primary products include NeuroSwift, a neurological diagnostic screening system that has received certifications from the U.S. FDA, EU CE MDR, and Taiwan TFDA for medical device approval. NeuroSwift Pro, designed for assessing central nervous and balance system disorders, is also FDA and TFDA certified. Additionally, the company offers the AIVertigo/NeuroSwift Pro+ system for brain disease classification and prediction, as well as eyeForm, a platform for predicting myopia risks. By leveraging advanced eye-tracking and AIVertigo technology, we aim to optimize diagnostic and treatment processes, enhance accuracy, and improve healthcare quality and patient well-being.